Draft Genome Sequence of an Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis from Nepal

Author:

Gautam Sanjay S.1,Leong Kelvin W. C.2,Pradhan Manoj3,Singh Y. Ibotomba3,Rajbhandari Sagar K.4,Ghimire Gokarna R.4,Adhikari Krishna4,Shrestha Uma4,Chaudhary Raina3,Ghimire Gyanendra3,Khadka Sundar5,O’Toole Ronan F.26

Affiliation:

1. School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania, Australia

2. School of Molecular Sciences, College of Science, Health and Engineering, La Trobe University, Victoria, Australia

3. Department of Microbiology, College of Medicine, Nepalese Army Institute of Health Sciences, Kathmandu, Nepal

4. National Tuberculosis Control Center, Bhaktapur, Nepal

5. HIV Reference Unit, National Public Health Laboratory, Kathmandu, Nepal

6. Trinity College Dublin, Department of Clinical Microbiology, Saint James’s Hospital, Dublin, Ireland

Abstract

Extensively drug-resistant (XDR) Mycobacterium tuberculosis has become a challenge to the treatment of tuberculosis (TB) in several countries, including Nepal. Here, we report for the first time the draft genome sequence of an isolate of XDR-TB collected in Nepal and describe single-nucleotide variations associated with its extensively drug-resistant phenotype.

Funder

La Trobe University

Publisher

American Society for Microbiology

Subject

Genetics,Immunology and Microbiology (miscellaneous),Molecular Biology

Reference18 articles.

1. World Health Organization. 2019. Global tuberculosis report. World Health Organization, Geneva, Switzerland.

2. Ministry of Health, Government of Nepal. 2016. National strategic plan for tuberculosis prevention, care and control 2016–2021. Ministry of Health, Government of Nepal, Kathmandu, Nepal.

3. World Health Organization. 2018. Global tuberculosis report. World Health Organization, Geneva, Switzerland.

4. Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in New Zealand

5. Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in Ireland

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3